相关实验视频
Updated: Jul 5, 2025
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.0K
从当前的免疫基因组学中解开新出现的门癌临床生物标志物取得了进步
Soledad Iseas1, Golubicki Mariano2, Louis Gros3
1Medical Oncology Department, Paris-St Joseph Hospital, 185 rue Raymond Losserand, 75014, Paris, France. soledad.iseas@gmail.com.
Molecular diagnosis & therapy
|January 24, 2024
概括
部状细胞癌 (ASCC) 是一种罕见的HPV相关癌症,正在迅速增加. 这篇评论分析了"omics"数据,以识别ASCC驱动基因,生物标志物和治疗点,敦促准确医学发展.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 胃肠病学 胃肠病学
背景情况:
- 部平细胞癌 (ASCC) 是一种罕见的恶性瘤,与高风险的人类乳头瘤病毒 (HPV) 有关.
- 在发达国家,ASCC的发病率和死亡率正在迅速增加.
- 关于ASCC中基因组数据表达和功能特征的临床研究有限.
研究的目的:
- 为ASCC全面审查"奥米克"研究的进展.
- 确定关键的ASCC癌症驱动基因表达和相关的信号通路.
- 突出生物标志物,治疗目标和ASCC的治疗机会.
主要方法:
- 基因组研究的系统分析.
- 评估最近最近的情况.
- 俄米克斯 (omicsics) 是一个电子产品.
- 研究的结果.
- 关于ASCC分子特征的文献综述.
主要成果:
- 识别相关的ASCC癌症驱动基因表达.
- 涉及ASCC的信号通路的表征.
- 突出癌进展和诊断潜力的重要生物标志物.
- 确定表达的治疗药物标和新兴的治疗策略.
结论:
- 在ASCC中迫切需要针对性治疗.
- 了解分子特征和药物向表达对于ASCC至关重要.
- 本综述为在门癌症中开发精准医学方法提供了见解.
相关概念视频
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
01:21Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348